ADAR1 Capital Management »

Achieve Life Sciences shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Achieve Life Sciences (ACHV) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Achieve Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Achieve Life Sciences held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achieve Life Sciences by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.0M 875k 4.55

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Achieve Life Sciences

Franklin Resources
Propel Bio Management
Sofinnova Ventures
Vanguard Group
ADAR1 Capital Management
Altium Capital Management
Nantahala Capital Management
CVI Holdings
Alyeska Investment Group
Shay Capital
Long Focus Capital Management
Susquehanna International
Simplify Asset Management
Geode Capital Management
Millennium Management

View all funds holding Achieve Life Sciences